Publishing research using ab16780? Please let us know so that we can cite the reference in this datasheet.

ab16780 has been referenced in 36 publications.

  • Luo Y  et al. ß-catenin nuclear translocation induced by HIF-1a overexpression leads to the radioresistance of prostate cancer. Int J Oncol 52:1827-1840 (2018). PubMed: 29658569
  • Kim S  et al. Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation. Cell Death Differ N/A:N/A (2018). PubMed: 30006610
  • He X & Fan S hsa-miR-212 modulates the radiosensitivity of glioma cells by targeting BRCA1. Oncol Rep 39:977-984 (2018). PubMed: 29286157
  • Zhao W  et al. BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing. Nature 550:360-365 (2017). WB . PubMed: 28976962
  • Zhang X  et al. Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines. Drugs R D 17:569-583 (2017). ICC/IF ; Human . PubMed: 28879638
  • Bourton EC  et al. The PARP-1 inhibitor Olaparib suppresses BRCA1 protein levels, increases apoptosis and causes radiation hypersensitivity in BRCA1+/- lymphoblastoid cells. J Cancer 8:4048-4056 (2017). ICC/IF ; Human . PubMed: 29187880
  • Irani S & Bidari-Zerehpoush F BRCA1/2 Mutations in Salivary Pleomorphic Adenoma and Carcinoma-ex-Pleomorphic Adenoma. J Int Soc Prev Community Dent 7:S155-S162 (2017). PubMed: 29285471
  • Wang H  et al. CD44+/CD24-phenotype predicts a poor prognosis in triple-negative breast cancer. Oncol Lett 14:5890-5898 (2017). PubMed: 29113223
  • Tan X  et al. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer. Oncotarget 7:293-307 (2016). IF . PubMed: 26588055
  • Wu L  et al. Aberrant promoter methylation of cancer-related genes in human breast cancer. Oncol Lett 12:5145-5155 (2016). PubMed: 28105221
  • Penterling C  et al. Depletion of Histone Demethylase Jarid1A Resulting in Histone Hyperacetylation and Radiation Sensitivity Does Not Affect DNA Double-Strand Break Repair. PLoS One 11:e0156599 (2016). IF . PubMed: 27253695
  • Zhao MJ  et al. Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy. Oncotarget 7:8956-67 (2016). IF . PubMed: 26788910
  • Onyango DO  et al. Tetratricopeptide repeat factor XAB2 mediates the end resection step of homologous recombination. Nucleic Acids Res 44:5702-16 (2016). ICC/IF . PubMed: 27084940
  • Wilson FR  et al. Cdk-dependent phosphorylation regulates TRF1 recruitment to PML bodies and promotes C-circle production in ALT cells. J Cell Sci 129:2559-72 (2016). PubMed: 27185864
  • Takata K  et al. Conserved overlapping gene arrangement, restricted expression, and biochemical activities of DNA polymerase ? (POLN). J Biol Chem 290:24278-93 (2015). WB ; Human . PubMed: 26269593
  • Boukerroucha M  et al. BRCA1 germline mutation and glioblastoma development: report of cases. BMC Cancer 15:181 (2015). PubMed: 25880076
  • Fan S  et al. Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis. Oncotarget 6:14885-904 (2015). WB, IHC, ChIP . PubMed: 25912308
  • Masuda Y  et al. TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin. Nat Commun 6:7299 (2015). Human . PubMed: 26095369
  • Zhu Q  et al. Autoimmune response to PARP and BRCA1/BRCA2 in cancer. Oncotarget 6:11575-84 (2015). IHC . PubMed: 25865228
  • Batenburg NL  et al. Cockayne syndrome group B protein regulates DNA double-strand break repair and checkpoint activation. EMBO J 34:1399-416 (2015). PubMed: 25820262
  • Li L  et al. Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancer. Sci Signal 7:ra47 (2014). PubMed: 24847116
  • Muñoz MC  et al. An RNF168 fragment defective for focal accumulation at DNA damage is proficient for inhibition of homologous recombination in BRCA1 deficient cells. Nucleic Acids Res 42:7720-33 (2014). WB . PubMed: 24829461
  • Wei JT  et al. Clinicopathological features and prognostic factors of young breast cancers in Eastern Guangdong of China. Sci Rep 4:5360 (2014). PubMed: 24942640
  • Hill SJ  et al. BRCA1 pathway function in basal-like breast cancer cells. Mol Cell Biol 34:3828-42 (2014). PubMed: 25092866
  • Kim HJ  et al. One Case of a BRCA1 Germ Line Mutation Ovarian Carcinoma Patient Based on Abnormal Immunohistochemistry Finding. Korean J Pathol 48:379-81 (2014). IHC ; Human . PubMed: 25366075
  • Birkenkamp-Demtröder K  et al. Keratin23 (KRT23) Knockdown Decreases Proliferation and Affects the DNA Damage Response of Colon Cancer Cells. PLoS One 8:e73593 (2013). WB ; Human . PubMed: 24039993
  • Almalki A  et al. Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes infantile-onset epilepsy and cytochrome c oxidase deficiency. Biochim Biophys Acta 1842:56-64 (2013). Human . PubMed: 24161539
  • McKerlie M  et al. Phosphorylated (pT371)TRF1 is recruited to sites of DNA damage to facilitate homologous recombination and checkpoint activation. Nucleic Acids Res N/A:N/A (2013). Human . PubMed: 23997120
  • Wu L  et al. BMS-345541 sensitizes MCF-7 breast cancer cells to ionizing radiation by selective inhibition of homologous recombinational repair of DNA double-strand breaks. Radiat Res 179:160-70 (2013). PubMed: 23259762
  • Muñoz MC  et al. RING finger nuclear factor RNF168 is important for defects in homologous recombination caused by loss of the breast cancer susceptibility factor BRCA1. J Biol Chem 287:40618-28 (2012). WB ; Human . PubMed: 23055523
  • Kaira K  et al. Prognostic significance of thymidylate synthase expression in the adjuvant chemotherapy after resection for pulmonary metastases from colorectal cancer. Anticancer Res 31:2763-71 (2011). IHC ; Human . PubMed: 21868518
  • Keimling M  et al. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways. FASEB J : (2011). PubMed: 21778326
  • Chène P  et al. Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue. BMC Chem Biol 9:1 (2009). IP ; Human . PubMed: 19128485
  • Geoffroy-Siraudin C  et al. Meiotic abnormalities in patients bearing complete AZFc deletion of Y chromosome. Hum Reprod 22:1567-72 (2007). ICC/IF ; Human . PubMed: 17428878
  • Wilson CA  et al. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 21:236-40 (1999). PubMed: 9988281
  • Scully R  et al. Location of BRCA1 in human breast and ovarian cancer cells. Science 272:123-6 (1996). PubMed: 8600523


Sign up